Blog Posts On Biospecimen Procurement For Industry

These blog posts examine the biobanking ecosystem from different points of view. First, the posts look at the needs of different industry users of biospecimens. These include biotechnology and pharmaceutical companies. Importantly, these are the companies we depend on for new therapies, vaccines and diagnostics. In addition, the posts describe the biospecimen providers. These include professional biobanks, hospitals, doctors and commercial intermediaries or brokers. Finally, the posts look at factors that block biospecimen procurement for the industry sector.

It is essential to realise that industry does not just need more biospecimens. It is also paramount for the biospecimens to be reliable. For companies to be confident of reliability, they must have adequate provenance information on each sample.

 

Biospecimen Procurement For Industry

02. Ensuring Public Support For Biobank  Cooperation With Industry

02. Ensuring Public Support For Biobank Cooperation With Industry

Public Attitudes to Biobank Cooperation With Industry In general, industry involvement in research tends to lower public trust. We see this effect whether the industry sector funds or conducts the investigation. Here are a few critical studies on the subject. A...

03. The Main Actors Providing Biosamples  To Industry

03. The Main Actors Providing Biosamples To Industry

Most human biosamples originate in the public sector. That is in public hospitals and publicly-funded population biobanks. So we need public-private partnerships for biosamples to reach the private sector.   Public-Private Partnerships in Biobanking This section...

04. Biosample Needs of Different Industry  Players

04. Biosample Needs of Different Industry Players

This article examines three different industry players that require biospecimen suppliers to meet their human tissue procurement needs. Large pharmaceutical companies Large in vitro diagnostics companies Small and medium enterprises (SMEs) in healthcare biotechnology...

05. The Dual Role of Academic Biobanks

05. The Dual Role of Academic Biobanks

Academic biobanks have a dual role: they must support two actors in a production that advances in patient care. The two actors they need to support are (1) researchers in academia and (2) researchers in industry. It is only by the efforts of both these actors that...

06. What is Commodification?

06. What is Commodification?

According to one dictionary definition, commodification is: 'The action or process of treating something as a mere commodity'. A commodity is 'a substance or product that can be traded, bought, or sold'. 'Commodification' is often used disapprovingly, especially...

07. Acceptable Transactions in Biobanking

07. Acceptable Transactions in Biobanking

What kind of financial transactions are legitimate for human biospecimens? There is some uncertainty about the correct answer to this question. There are also some differences of opinion.   The Oviedo Convention The Council of Europe’s Oviedo Convention (1997) is...

08. Why Biobank Access Policies Should Be  Publicly Available

08. Why Biobank Access Policies Should Be Publicly Available

 It is not easy for industry researchers to find suitable academic biobanks. For one thing, the biobank needs to have the biosamples required. For another, it must have policies that allow industry access. Unfortunately, biobank access policies may contain exclusion...

09. Biospecimen Provenance: What Researchers  Need To Know

09. Biospecimen Provenance: What Researchers Need To Know

Every biosample or tissue sample used for medical research has a different journey. The journey starts when a person donates a biosample and it ends when a researcher analyses the same sample. In between, there are a wide variety of possible routes, events and...

Associated Articles on Biospecimen Procurement For Industry

There are a series of online media articles related to these blog posts on biospecimen procurement for industry. The articles focus on the biosample procurement problems facing biotech companies in particular. Furthermore, they explain that the ideal solution is for academic biobanks to work directly with biotech companies. The Biosample Hub platform is one practical way to make this possible.

There are over 20 online media articles in this series. Examples include:

You can see all the articles listed at the bottom of the Biosample Hub home page.